Ask Indegene Icon

Ask Indegene (Beta)

Online
🧠 Building on our previous conversation...

Hello, how can I help you today?

You may type your question or choose from the options below:

Explore Solutions
Browse Insights
View Case Studies
Read Latest News
Explore Careers
Connect with an Expert
Please enter your full name
Please enter a valid work email
Please enter your message

Thank you!

We'll be in touch. In the meantime, feel free to keep exploring!

#PractitionerLevelConfidence

Indegene
Search Icon
MM+M Podcast: Why Europe wants to close the orphan drug loophole
Home
News

MM+M Podcast: Why Europe wants to close the orphan drug loophole

14 JUN 2022

Preferential treatment for orphan drugs is very much in play overseas. Pricing guru Jack Mycka, VP in the PRMA division of Indegene, explains what potential European reforms could mean for pharma marketers in light of U.S. pressure to reform drug pricing.

For more details, please refer to:

https://the-mm-m-podcast-e341ae22.simplecast.com/episodes/mmm-podcast-61422-why-europe-wants-to-close-the-orphan-drug-loophole

Latest

Let's Partner to Commercialize with Confidence

Powered by Onetrust